Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs

Erstveröffentlichung

2012

Authors

Verhoef, Talitha I.

Redekop, William K.

van Schie, Rianne M. F.

Bayat, Samira

Daly, Ann K.

et al.

Wissenschaftlicher Artikel

Published in

Pharmacogenomics ; 13 (2012), 12. - S. 1405-1417. - ISSN 1462-2416. - eISSN 1744-8042

Link to publication

https://dx.doi.org/10.2217/PGS.12.124

Institutions

UKU. Institut für Naturheilkunde und Klinische Pharmakologie

EU Project uulm

EU-PACT / A pharmacogenomic approach to coumarin anticoagulant therapy / EC / FP7 / 223062

Subject headings

[Free subject headings]: acenocoumarol | atrial fibrillation | cost analysis | coumarins | health | economics | healthcare system | phenprocoumon | warfarin | NONVALVULAR ATRIAL-FIBRILLATION | DEEP VENOUS THROMBOSIS | ORAL ANTICOAGULATION | SELF-MANAGEMENT | BLEEDING COMPLICATIONS | WARFARIN THERAPY | INTRACEREBRAL HEMORRHAGE | DABIGATRAN ETEXILATE | ECONOMIC OUTCOMES | STROKE
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record